| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Swine | 157 | 2025 | 1210 | 8.170 |
Why?
|
| Animals, Newborn | 103 | 2025 | 1017 | 6.730 |
Why?
|
| Intestinal Mucosa | 64 | 2021 | 778 | 5.020 |
Why?
|
| Bile Acids and Salts | 19 | 2025 | 244 | 4.860 |
Why?
|
| Parenteral Nutrition | 20 | 2025 | 195 | 4.450 |
Why?
|
| Fat Emulsions, Intravenous | 9 | 2025 | 77 | 4.320 |
Why?
|
| Enteral Nutrition | 34 | 2023 | 257 | 4.190 |
Why?
|
| Intestines | 43 | 2023 | 577 | 4.170 |
Why?
|
| Parenteral Nutrition, Total | 23 | 2014 | 113 | 3.240 |
Why?
|
| Cholestasis | 9 | 2025 | 154 | 3.200 |
Why?
|
| Enterocolitis, Necrotizing | 20 | 2023 | 244 | 3.100 |
Why?
|
| Infant, Premature | 23 | 2023 | 829 | 2.830 |
Why?
|
| Liver | 34 | 2025 | 1749 | 2.680 |
Why?
|
| Protein Biosynthesis | 40 | 2022 | 663 | 2.550 |
Why?
|
| Liver Diseases | 7 | 2023 | 368 | 2.520 |
Why?
|
| Glucagon-Like Peptide 2 | 27 | 2019 | 54 | 2.460 |
Why?
|
| Intestine, Small | 23 | 2019 | 307 | 2.440 |
Why?
|
| Amino Acids | 42 | 2023 | 668 | 2.330 |
Why?
|
| Colostrum | 20 | 2021 | 56 | 2.320 |
Why?
|
| Intestinal Absorption | 25 | 2019 | 190 | 2.310 |
Why?
|
| Animals | 201 | 2025 | 34241 | 2.300 |
Why?
|
| Fibroblast Growth Factors | 9 | 2023 | 152 | 2.290 |
Why?
|
| Soybean Oil | 10 | 2025 | 70 | 2.210 |
Why?
|
| Premature Birth | 18 | 2023 | 387 | 1.950 |
Why?
|
| Sus scrofa | 12 | 2020 | 129 | 1.890 |
Why?
|
| Glutamic Acid | 16 | 2013 | 203 | 1.740 |
Why?
|
| Phytosterols | 5 | 2021 | 28 | 1.690 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 7 | 2022 | 376 | 1.630 |
Why?
|
| Arginine | 8 | 2024 | 336 | 1.590 |
Why?
|
| Insulin-Like Growth Factor I | 18 | 2023 | 341 | 1.480 |
Why?
|
| Citrulline | 6 | 2024 | 111 | 1.480 |
Why?
|
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 193 | 1.470 |
Why?
|
| Disease Models, Animal | 21 | 2025 | 4396 | 1.450 |
Why?
|
| Peptides | 12 | 2014 | 811 | 1.410 |
Why?
|
| Short Bowel Syndrome | 8 | 2020 | 65 | 1.330 |
Why?
|
| Milk, Human | 7 | 2023 | 300 | 1.270 |
Why?
|
| Dietary Supplements | 9 | 2023 | 472 | 1.250 |
Why?
|
| Gastrointestinal Tract | 10 | 2023 | 216 | 1.250 |
Why?
|
| Phospholipids | 3 | 2019 | 106 | 1.230 |
Why?
|
| Fish Oils | 7 | 2021 | 85 | 1.210 |
Why?
|
| Vitamin E | 3 | 2019 | 69 | 1.210 |
Why?
|
| Dietary Proteins | 13 | 2018 | 252 | 1.210 |
Why?
|
| Infant, Newborn | 35 | 2023 | 8240 | 1.170 |
Why?
|
| Amino Acids, Sulfur | 4 | 2009 | 15 | 1.160 |
Why?
|
| Digestive System | 11 | 2003 | 63 | 1.160 |
Why?
|
| Gastrointestinal Microbiome | 8 | 2023 | 702 | 1.140 |
Why?
|
| Methionine | 6 | 2011 | 102 | 1.120 |
Why?
|
| Homeostasis | 7 | 2022 | 703 | 1.100 |
Why?
|
| Swine Diseases | 4 | 2020 | 37 | 1.070 |
Why?
|
| Ileum | 6 | 2020 | 132 | 1.070 |
Why?
|
| Lipid Metabolism | 3 | 2022 | 357 | 1.020 |
Why?
|
| Glucagon-Like Peptides | 13 | 2011 | 35 | 1.010 |
Why?
|
| Jejunum | 15 | 2020 | 127 | 0.960 |
Why?
|
| Triglycerides | 7 | 2021 | 575 | 0.940 |
Why?
|
| Glucose | 14 | 2024 | 878 | 0.920 |
Why?
|
| Animal Feed | 10 | 2020 | 77 | 0.900 |
Why?
|
| Lactose | 4 | 2018 | 54 | 0.890 |
Why?
|
| Models, Animal | 11 | 2022 | 464 | 0.880 |
Why?
|
| Endotoxemia | 1 | 2024 | 59 | 0.870 |
Why?
|
| Muscle, Skeletal | 21 | 2023 | 946 | 0.850 |
Why?
|
| Animal Nutritional Physiological Phenomena | 14 | 2021 | 63 | 0.850 |
Why?
|
| beta Carotene | 1 | 2023 | 41 | 0.840 |
Why?
|
| Signal Transduction | 15 | 2022 | 4536 | 0.830 |
Why?
|
| Polyethylene Glycols | 1 | 2024 | 240 | 0.810 |
Why?
|
| Probiotics | 5 | 2023 | 214 | 0.810 |
Why?
|
| Docosahexaenoic Acids | 3 | 2019 | 68 | 0.800 |
Why?
|
| Organ Size | 21 | 2023 | 440 | 0.800 |
Why?
|
| Emulsions | 6 | 2025 | 69 | 0.790 |
Why?
|
| High Fructose Corn Syrup | 2 | 2021 | 7 | 0.790 |
Why?
|
| Hydrocortisone | 2 | 2022 | 218 | 0.780 |
Why?
|
| Cesarean Section | 4 | 2021 | 389 | 0.780 |
Why?
|
| Parturition | 1 | 2022 | 63 | 0.770 |
Why?
|
| Biliary Atresia | 1 | 2025 | 190 | 0.770 |
Why?
|
| Splanchnic Circulation | 8 | 2014 | 53 | 0.770 |
Why?
|
| Inflammation | 7 | 2024 | 1446 | 0.750 |
Why?
|
| Diet | 19 | 2020 | 1140 | 0.740 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 6 | 2022 | 398 | 0.730 |
Why?
|
| Pregnancy | 31 | 2023 | 7223 | 0.710 |
Why?
|
| Female | 89 | 2025 | 66885 | 0.700 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 307 | 0.680 |
Why?
|
| Food, Formulated | 6 | 2020 | 52 | 0.680 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2021 | 173 | 0.670 |
Why?
|
| Colitis | 2 | 2012 | 151 | 0.670 |
Why?
|
| Growth Hormone | 7 | 2004 | 150 | 0.660 |
Why?
|
| Dietary Fats | 2 | 2022 | 294 | 0.650 |
Why?
|
| Nutritional Physiological Phenomena | 11 | 2019 | 93 | 0.650 |
Why?
|
| Adaptation, Physiological | 10 | 2019 | 271 | 0.640 |
Why?
|
| Milk | 9 | 2020 | 119 | 0.640 |
Why?
|
| Epithelial Cells | 5 | 2013 | 909 | 0.640 |
Why?
|
| Nitric Oxide | 4 | 2018 | 494 | 0.630 |
Why?
|
| Glutamine | 7 | 2012 | 215 | 0.620 |
Why?
|
| Rifampin | 1 | 2019 | 131 | 0.620 |
Why?
|
| Random Allocation | 13 | 2021 | 441 | 0.610 |
Why?
|
| Receptors, Glucagon | 7 | 2017 | 28 | 0.610 |
Why?
|
| Insulin | 18 | 2024 | 1203 | 0.610 |
Why?
|
| Cattle | 11 | 2021 | 569 | 0.610 |
Why?
|
| Lactase | 8 | 2009 | 40 | 0.600 |
Why?
|
| Clostridium | 1 | 2018 | 17 | 0.600 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 16 | 0.600 |
Why?
|
| Bacillus | 1 | 2018 | 35 | 0.590 |
Why?
|
| Kidney | 8 | 2019 | 1369 | 0.580 |
Why?
|
| Homocysteine | 5 | 2011 | 123 | 0.570 |
Why?
|
| Kupffer Cells | 1 | 2017 | 18 | 0.570 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2019 | 56 | 0.570 |
Why?
|
| Endotoxins | 1 | 2017 | 48 | 0.570 |
Why?
|
| Lipopolysaccharides | 4 | 2024 | 297 | 0.560 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 119 | 0.560 |
Why?
|
| Gastrointestinal Diseases | 3 | 2017 | 339 | 0.560 |
Why?
|
| Humans | 76 | 2023 | 125392 | 0.560 |
Why?
|
| Proteins | 16 | 2006 | 1036 | 0.550 |
Why?
|
| Microbiota | 2 | 2020 | 389 | 0.550 |
Why?
|
| Infant, Premature, Diseases | 3 | 2014 | 244 | 0.540 |
Why?
|
| Hepatocytes | 2 | 2017 | 211 | 0.530 |
Why?
|
| Food | 1 | 2017 | 125 | 0.520 |
Why?
|
| Infant Formula | 6 | 2023 | 96 | 0.520 |
Why?
|
| Insulin Resistance | 5 | 2021 | 641 | 0.520 |
Why?
|
| Phenylalanine | 12 | 2005 | 128 | 0.500 |
Why?
|
| Digestion | 4 | 2017 | 41 | 0.490 |
Why?
|
| Sodium Glutamate | 2 | 2013 | 6 | 0.490 |
Why?
|
| Fatty Acids | 5 | 2022 | 344 | 0.490 |
Why?
|
| Gastric Emptying | 2 | 2013 | 79 | 0.480 |
Why?
|
| Body Weight | 17 | 2023 | 989 | 0.480 |
Why?
|
| Nutritional Support | 3 | 2020 | 55 | 0.470 |
Why?
|
| Ketoglutaric Acids | 2 | 2006 | 24 | 0.470 |
Why?
|
| Eating | 10 | 2019 | 368 | 0.470 |
Why?
|
| Lactase-Phlorizin Hydrolase | 8 | 2002 | 21 | 0.460 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2011 | 97 | 0.460 |
Why?
|
| Fatty Liver | 3 | 2012 | 188 | 0.450 |
Why?
|
| Muscle Proteins | 10 | 2022 | 416 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1271 | 0.430 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 3 | 2021 | 34 | 0.430 |
Why?
|
| Gestational Age | 9 | 2022 | 1168 | 0.430 |
Why?
|
| Amino Acids, Essential | 5 | 2018 | 26 | 0.420 |
Why?
|
| Nitrogen | 7 | 2018 | 146 | 0.420 |
Why?
|
| Viscera | 10 | 2012 | 55 | 0.410 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2014 | 70 | 0.410 |
Why?
|
| Weight Gain | 15 | 2019 | 400 | 0.410 |
Why?
|
| Gastric Mucosa | 4 | 2009 | 488 | 0.410 |
Why?
|
| Animals, Domestic | 3 | 2017 | 31 | 0.400 |
Why?
|
| Mesenteric Artery, Superior | 3 | 2014 | 35 | 0.400 |
Why?
|
| Cell Survival | 3 | 2010 | 814 | 0.400 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2014 | 1698 | 0.400 |
Why?
|
| Thionucleosides | 1 | 2012 | 6 | 0.400 |
Why?
|
| Gene Expression | 6 | 2014 | 1560 | 0.390 |
Why?
|
| Blood Glucose | 19 | 2019 | 1132 | 0.390 |
Why?
|
| Nutritional Requirements | 4 | 2020 | 181 | 0.380 |
Why?
|
| Animals, Suckling | 7 | 2003 | 50 | 0.380 |
Why?
|
| Glucagon-Like Peptide 1 | 4 | 2017 | 70 | 0.380 |
Why?
|
| Cells, Cultured | 7 | 2017 | 3056 | 0.380 |
Why?
|
| Vitamin B 6 Deficiency | 1 | 2011 | 6 | 0.370 |
Why?
|
| Adenosine | 1 | 2012 | 127 | 0.360 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2022 | 429 | 0.360 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2011 | 42 | 0.360 |
Why?
|
| Oxidation-Reduction | 11 | 2012 | 443 | 0.360 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2025 | 48 | 0.350 |
Why?
|
| Cell Division | 7 | 2009 | 781 | 0.350 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 130 | 0.350 |
Why?
|
| Sheep | 4 | 1992 | 220 | 0.340 |
Why?
|
| Hepatitis | 1 | 2010 | 57 | 0.340 |
Why?
|
| Isotope Labeling | 4 | 2009 | 105 | 0.340 |
Why?
|
| Leucine | 12 | 2023 | 310 | 0.330 |
Why?
|
| Up-Regulation | 4 | 2020 | 867 | 0.330 |
Why?
|
| Brain | 10 | 2023 | 3004 | 0.330 |
Why?
|
| Pancreas | 6 | 2019 | 221 | 0.320 |
Why?
|
| Proline | 2 | 2012 | 78 | 0.320 |
Why?
|
| Milk Proteins | 2 | 2021 | 92 | 0.320 |
Why?
|
| Portal System | 10 | 2007 | 34 | 0.320 |
Why?
|
| Oxidative Stress | 2 | 2014 | 837 | 0.310 |
Why?
|
| Male | 40 | 2025 | 61663 | 0.310 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2015 | 145 | 0.300 |
Why?
|
| Microvilli | 7 | 2013 | 71 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 685 | 0.300 |
Why?
|
| Food, Fortified | 3 | 2018 | 96 | 0.300 |
Why?
|
| Kinetics | 13 | 2012 | 1333 | 0.290 |
Why?
|
| Tritium | 10 | 2009 | 173 | 0.280 |
Why?
|
| Hyperbilirubinemia | 2 | 2019 | 40 | 0.280 |
Why?
|
| Bacterial Infections | 2 | 2021 | 308 | 0.270 |
Why?
|
| Carbon Isotopes | 11 | 2012 | 277 | 0.270 |
Why?
|
| Apoptosis | 5 | 2006 | 1806 | 0.260 |
Why?
|
| Colon | 4 | 2020 | 351 | 0.260 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2022 | 292 | 0.260 |
Why?
|
| Oxygen Consumption | 7 | 2011 | 305 | 0.260 |
Why?
|
| RNA, Messenger | 11 | 2019 | 2820 | 0.260 |
Why?
|
| Plant Oils | 3 | 2018 | 33 | 0.250 |
Why?
|
| Organoids | 2 | 2021 | 281 | 0.250 |
Why?
|
| Sucrase | 5 | 2017 | 22 | 0.250 |
Why?
|
| Hexoses | 1 | 2005 | 11 | 0.250 |
Why?
|
| Carbon Dioxide | 6 | 2013 | 279 | 0.250 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 211 | 0.250 |
Why?
|
| Galactose | 3 | 2009 | 54 | 0.250 |
Why?
|
| Spleen | 3 | 2006 | 281 | 0.250 |
Why?
|
| Analysis of Variance | 6 | 2011 | 1020 | 0.240 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 62 | 0.240 |
Why?
|
| Malabsorption Syndromes | 1 | 2005 | 36 | 0.240 |
Why?
|
| Peroxidase | 3 | 2012 | 69 | 0.240 |
Why?
|
| Portal Vein | 7 | 2012 | 94 | 0.240 |
Why?
|
| Norovirus | 2 | 2021 | 317 | 0.240 |
Why?
|
| Intestine, Large | 2 | 2001 | 14 | 0.230 |
Why?
|
| Cytokines | 4 | 2024 | 1289 | 0.230 |
Why?
|
| Proglucagon | 2 | 2017 | 5 | 0.230 |
Why?
|
| Nutritional Status | 5 | 2020 | 315 | 0.230 |
Why?
|
| Glycoproteins | 3 | 2021 | 370 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2020 | 1005 | 0.230 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2004 | 6 | 0.230 |
Why?
|
| DNA | 9 | 2005 | 1609 | 0.230 |
Why?
|
| Blood Proteins | 4 | 2000 | 124 | 0.230 |
Why?
|
| Hydrolases | 1 | 2024 | 56 | 0.220 |
Why?
|
| Growth Substances | 2 | 2002 | 113 | 0.220 |
Why?
|
| Fructose | 2 | 2021 | 62 | 0.220 |
Why?
|
| Infant Food | 4 | 2007 | 81 | 0.220 |
Why?
|
| Nitric Oxide Synthase Type III | 3 | 2010 | 219 | 0.220 |
Why?
|
| Energy Metabolism | 9 | 2021 | 766 | 0.220 |
Why?
|
| Blotting, Western | 4 | 2014 | 1102 | 0.220 |
Why?
|
| Obstetric Labor, Premature | 2 | 2013 | 85 | 0.220 |
Why?
|
| Zeaxanthins | 1 | 2023 | 9 | 0.220 |
Why?
|
| Lutein | 1 | 2023 | 15 | 0.220 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 1999 | 32 | 0.220 |
Why?
|
| Time Factors | 14 | 2013 | 6345 | 0.210 |
Why?
|
| Muscles | 4 | 1996 | 292 | 0.210 |
Why?
|
| Intestinal Diseases | 2 | 2021 | 83 | 0.210 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.210 |
Why?
|
| Symporters | 1 | 2004 | 70 | 0.210 |
Why?
|
| Growth | 4 | 2014 | 106 | 0.210 |
Why?
|
| Vitamin A | 1 | 2023 | 59 | 0.210 |
Why?
|
| Sulfates | 2 | 2022 | 35 | 0.210 |
Why?
|
| Regional Blood Flow | 5 | 2012 | 210 | 0.210 |
Why?
|
| Infant | 9 | 2023 | 12518 | 0.210 |
Why?
|
| Swine, Miniature | 5 | 2016 | 50 | 0.210 |
Why?
|
| Sodium-Glucose Transporter 1 | 3 | 2010 | 11 | 0.200 |
Why?
|
| Carotenoids | 1 | 2023 | 75 | 0.200 |
Why?
|
| Immunity | 2 | 2020 | 192 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2314 | 0.200 |
Why?
|
| Cysteine | 3 | 2009 | 139 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 1290 | 0.200 |
Why?
|
| Endocrine System | 1 | 2022 | 22 | 0.190 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2021 | 2 | 0.190 |
Why?
|
| Metabolomics | 2 | 2019 | 423 | 0.190 |
Why?
|
| Abdomen | 2 | 2015 | 127 | 0.190 |
Why?
|
| Duodenum | 2 | 2020 | 100 | 0.190 |
Why?
|
| Incidence | 2 | 2023 | 3154 | 0.190 |
Why?
|
| Dextran Sulfate | 2 | 2012 | 47 | 0.190 |
Why?
|
| Models, Biological | 8 | 2009 | 1461 | 0.190 |
Why?
|
| Myofibrils | 2 | 2001 | 28 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2019 | 302 | 0.190 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 132 | 0.190 |
Why?
|
| Glycolipids | 1 | 2021 | 32 | 0.190 |
Why?
|
| Biological Availability | 4 | 2012 | 137 | 0.190 |
Why?
|
| Threonine | 4 | 2012 | 60 | 0.190 |
Why?
|
| Disaccharidases | 2 | 1991 | 15 | 0.190 |
Why?
|
| Glutathione | 3 | 2011 | 196 | 0.180 |
Why?
|
| Fetus | 2 | 2022 | 585 | 0.180 |
Why?
|
| Stomach | 5 | 2009 | 270 | 0.180 |
Why?
|
| Vagina | 1 | 2022 | 185 | 0.180 |
Why?
|
| Oxylipins | 1 | 2021 | 5 | 0.180 |
Why?
|
| Dietary Sucrose | 1 | 2021 | 42 | 0.180 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 20 | 0.180 |
Why?
|
| Gastrointestinal Hormones | 1 | 2001 | 23 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2021 | 75 | 0.180 |
Why?
|
| Lipid Droplets | 1 | 2021 | 46 | 0.180 |
Why?
|
| Muscle Development | 5 | 2000 | 71 | 0.180 |
Why?
|
| Feeding Methods | 1 | 2001 | 37 | 0.180 |
Why?
|
| Immunoglobulins | 1 | 2021 | 173 | 0.180 |
Why?
|
| Biomarkers | 3 | 2021 | 3096 | 0.180 |
Why?
|
| Body Composition | 6 | 2023 | 521 | 0.180 |
Why?
|
| Oxygen | 3 | 2014 | 557 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2001 | 358 | 0.180 |
Why?
|
| Rats | 10 | 2014 | 3727 | 0.170 |
Why?
|
| Soybean Proteins | 1 | 2000 | 17 | 0.170 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 93 | 0.170 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2017 | 19 | 0.170 |
Why?
|
| Protein-Energy Malnutrition | 3 | 1997 | 76 | 0.170 |
Why?
|
| Lactalbumin | 1 | 2020 | 11 | 0.170 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 162 | 0.170 |
Why?
|
| Whey Proteins | 1 | 2020 | 6 | 0.170 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 196 | 0.170 |
Why?
|
| Aging | 6 | 2019 | 1182 | 0.170 |
Why?
|
| Choline | 1 | 2020 | 54 | 0.160 |
Why?
|
| Adiposity | 1 | 2021 | 190 | 0.160 |
Why?
|
| RNA, Transfer, Amino Acyl | 1 | 1999 | 5 | 0.160 |
Why?
|
| Growth Disorders | 1 | 2021 | 209 | 0.160 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 31 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 1203 | 0.160 |
Why?
|
| Progesterone | 1 | 2022 | 623 | 0.160 |
Why?
|
| Placental Circulation | 1 | 2019 | 24 | 0.160 |
Why?
|
| Phosphorylation | 3 | 2010 | 1631 | 0.160 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 59 | 0.160 |
Why?
|
| Sitosterols | 1 | 2019 | 9 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 68 | 0.160 |
Why?
|
| Immune System | 1 | 2020 | 90 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2022 | 233 | 0.150 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2019 | 81 | 0.150 |
Why?
|
| Olive Oil | 2 | 2019 | 22 | 0.150 |
Why?
|
| beta-Galactosidase | 4 | 2001 | 147 | 0.150 |
Why?
|
| Urea | 4 | 2012 | 231 | 0.150 |
Why?
|
| Infusions, Parenteral | 2 | 2021 | 100 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 293 | 0.150 |
Why?
|
| Fetal Blood | 1 | 2019 | 177 | 0.150 |
Why?
|
| Risk Factors | 6 | 2020 | 10331 | 0.150 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2017 | 6 | 0.140 |
Why?
|
| Phenotype | 2 | 2024 | 4263 | 0.140 |
Why?
|
| Mice | 8 | 2017 | 17637 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 249 | 0.140 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 4 | 2014 | 10 | 0.140 |
Why?
|
| Methylation | 2 | 2009 | 221 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2023 | 166 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 25 | 0.140 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2017 | 37 | 0.140 |
Why?
|
| Micelles | 1 | 2017 | 16 | 0.140 |
Why?
|
| Dexamethasone | 1 | 1999 | 276 | 0.140 |
Why?
|
| Virus Replication | 2 | 2021 | 607 | 0.140 |
Why?
|
| Administration, Oral | 5 | 2017 | 685 | 0.140 |
Why?
|
| alpha-Glucosidases | 5 | 2013 | 28 | 0.140 |
Why?
|
| Fetal Diseases | 1 | 2021 | 456 | 0.140 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 29 | 0.140 |
Why?
|
| Fetal Development | 1 | 2018 | 132 | 0.130 |
Why?
|
| Organ Culture Techniques | 1 | 2017 | 156 | 0.130 |
Why?
|
| Food Deprivation | 2 | 2008 | 32 | 0.130 |
Why?
|
| Infusions, Intravenous | 5 | 2014 | 555 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 367 | 0.130 |
Why?
|
| Palmitic Acid | 1 | 2016 | 34 | 0.130 |
Why?
|
| Atrophy | 4 | 2014 | 231 | 0.130 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 33 | 0.130 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2017 | 62 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 10 | 0.130 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2016 | 7 | 0.130 |
Why?
|
| Virus Cultivation | 1 | 2016 | 76 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 187 | 0.130 |
Why?
|
| Digestive System Physiological Phenomena | 3 | 2002 | 10 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 162 | 0.130 |
Why?
|
| Neurons | 4 | 2017 | 1932 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 1999 | 383 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 81 | 0.130 |
Why?
|
| Malnutrition | 1 | 2019 | 207 | 0.130 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2016 | 55 | 0.120 |
Why?
|
| Lactoferrin | 1 | 1996 | 78 | 0.120 |
Why?
|
| Lipids | 2 | 2022 | 523 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 108 | 0.120 |
Why?
|
| Enzyme Precursors | 4 | 2004 | 25 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2013 | 489 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2006 | 63 | 0.120 |
Why?
|
| Bottle Feeding | 1 | 2015 | 36 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 4406 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 30 | 0.120 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 667 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 509 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 325 | 0.120 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 33 | 0.120 |
Why?
|
| Metabolism | 2 | 2005 | 42 | 0.120 |
Why?
|
| Alanine | 4 | 2023 | 187 | 0.120 |
Why?
|
| Mucin-2 | 2 | 2012 | 41 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 1999 | 781 | 0.120 |
Why?
|
| Child Development | 1 | 2017 | 266 | 0.110 |
Why?
|
| Cholestenones | 1 | 2014 | 7 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 514 | 0.110 |
Why?
|
| Sorbitol | 1 | 2014 | 8 | 0.110 |
Why?
|
| Permeability | 3 | 2018 | 125 | 0.110 |
Why?
|
| Dipeptides | 1 | 1994 | 57 | 0.110 |
Why?
|
| Mothers | 1 | 2017 | 356 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 1693 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 207 | 0.110 |
Why?
|
| Ampicillin | 1 | 2013 | 56 | 0.110 |
Why?
|
| Cell Count | 2 | 2004 | 254 | 0.110 |
Why?
|
| Animals, Inbred Strains | 1 | 2013 | 5 | 0.110 |
Why?
|
| Lysine | 4 | 2003 | 196 | 0.110 |
Why?
|
| Reference Values | 4 | 2014 | 718 | 0.110 |
Why?
|
| Gastroenteritis | 1 | 2016 | 349 | 0.110 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 87 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2019 | 12412 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 187 | 0.100 |
Why?
|
| Gentamicins | 1 | 2013 | 95 | 0.100 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 328 | 0.100 |
Why?
|
| Caprylates | 1 | 2013 | 12 | 0.100 |
Why?
|
| RNA | 6 | 1997 | 570 | 0.100 |
Why?
|
| Transcriptome | 1 | 2019 | 955 | 0.100 |
Why?
|
| Infant, Low Birth Weight | 1 | 2014 | 167 | 0.100 |
Why?
|
| Catheterization | 3 | 2008 | 235 | 0.100 |
Why?
|
| Enteroendocrine Cells | 2 | 2019 | 21 | 0.100 |
Why?
|
| Metronidazole | 1 | 2013 | 154 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2014 | 267 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 139 | 0.100 |
Why?
|
| Obesity | 2 | 2024 | 2252 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 25 | 0.100 |
Why?
|
| Ornithine | 1 | 2012 | 31 | 0.100 |
Why?
|
| Congresses as Topic | 1 | 2014 | 175 | 0.100 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 80 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 482 | 0.100 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 51 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 1992 | 23 | 0.100 |
Why?
|
| Liver Circulation | 3 | 2003 | 24 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2012 | 56 | 0.100 |
Why?
|
| Incretins | 1 | 2012 | 24 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1122 | 0.100 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2011 | 13 | 0.100 |
Why?
|
| Myocardium | 1 | 1997 | 1021 | 0.100 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 143 | 0.090 |
Why?
|
| Pyridoxal Phosphate | 1 | 2011 | 14 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 149 | 0.090 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2011 | 16 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 229 | 0.090 |
Why?
|
| Methylmalonic Acid | 1 | 2011 | 15 | 0.090 |
Why?
|
| Asthma | 1 | 2019 | 756 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 335 | 0.090 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 504 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 94 | 0.090 |
Why?
|
| Glutamates | 1 | 1991 | 68 | 0.090 |
Why?
|
| Peptide YY | 2 | 2001 | 19 | 0.090 |
Why?
|
| Energy Intake | 2 | 2010 | 494 | 0.090 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 59 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 20 | 0.090 |
Why?
|
| Weaning | 3 | 2019 | 44 | 0.090 |
Why?
|
| Enterocytes | 2 | 2016 | 74 | 0.090 |
Why?
|
| Pregnancy, Animal | 2 | 2011 | 75 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2011 | 174 | 0.080 |
Why?
|
| Isotopes | 1 | 2009 | 27 | 0.080 |
Why?
|
| Fasting | 5 | 2002 | 294 | 0.080 |
Why?
|
| Nutritive Value | 2 | 2020 | 91 | 0.080 |
Why?
|
| Glucagon | 2 | 2017 | 184 | 0.080 |
Why?
|
| Lung | 1 | 1997 | 1496 | 0.080 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2009 | 4 | 0.080 |
Why?
|
| Nitrogen Isotopes | 1 | 2009 | 63 | 0.080 |
Why?
|
| Child | 5 | 2021 | 24436 | 0.080 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 74 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 233 | 0.080 |
Why?
|
| Dysbiosis | 2 | 2020 | 122 | 0.080 |
Why?
|
| Starvation | 1 | 1988 | 15 | 0.080 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2015 | 19 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1058 | 0.070 |
Why?
|
| Goblet Cells | 1 | 2009 | 103 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2005 | 391 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 173 | 0.070 |
Why?
|
| Caspases | 2 | 2006 | 162 | 0.070 |
Why?
|
| Postprandial Period | 2 | 2004 | 77 | 0.070 |
Why?
|
| Sulfur Compounds | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2007 | 14 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2522 | 0.070 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 29 | 0.070 |
Why?
|
| Dogs | 3 | 2003 | 775 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 95 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 1972 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2001 | 1699 | 0.060 |
Why?
|
| Protein Deficiency | 2 | 1996 | 20 | 0.060 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2006 | 17 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 111 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 435 | 0.060 |
Why?
|
| DNA Primers | 1 | 2007 | 657 | 0.060 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2005 | 8 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2917 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3075 | 0.060 |
Why?
|
| Algorithms | 3 | 2009 | 1630 | 0.060 |
Why?
|
| Mesenteric Arteries | 1 | 2006 | 57 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 2756 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 458 | 0.060 |
Why?
|
| Fetal Growth Retardation | 2 | 1997 | 239 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2019 | 344 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2004 | 32 | 0.060 |
Why?
|
| Critical Illness | 1 | 2009 | 601 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 3892 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 332 | 0.060 |
Why?
|
| CD13 Antigens | 2 | 2001 | 10 | 0.060 |
Why?
|
| Texas | 1 | 2013 | 3589 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2004 | 132 | 0.060 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2004 | 4 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 2433 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 763 | 0.060 |
Why?
|
| Gastrins | 2 | 2002 | 33 | 0.060 |
Why?
|
| Hormones | 2 | 2002 | 186 | 0.060 |
Why?
|
| Jejunostomy | 2 | 2014 | 21 | 0.060 |
Why?
|
| Stem Cells | 2 | 2021 | 708 | 0.050 |
Why?
|
| Claudin-1 | 1 | 2003 | 20 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2001 | 176 | 0.050 |
Why?
|
| Pancreatic Hormones | 1 | 2003 | 4 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2003 | 39 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2003 | 24 | 0.050 |
Why?
|
| Diuresis | 1 | 2003 | 58 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2003 | 63 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 1410 | 0.050 |
Why?
|
| Rodentia | 1 | 2003 | 45 | 0.050 |
Why?
|
| Enteritis | 1 | 2003 | 54 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 41 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2002 | 77 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 2397 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 63 | 0.050 |
Why?
|
| Chickens | 1 | 2003 | 636 | 0.050 |
Why?
|
| Age Factors | 3 | 2020 | 2827 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 2714 | 0.050 |
Why?
|
| Gastrointestinal Motility | 1 | 2002 | 48 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2002 | 54 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2022 | 53 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 1586 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 462 | 0.050 |
Why?
|
| Diet, Western | 1 | 2021 | 17 | 0.050 |
Why?
|
| Neuroglia | 1 | 2004 | 204 | 0.050 |
Why?
|
| Deuterium | 3 | 1997 | 109 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2004 | 428 | 0.050 |
Why?
|
| Growth and Development | 1 | 2021 | 22 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 38 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2002 | 151 | 0.050 |
Why?
|
| Nucleotides | 1 | 2002 | 92 | 0.050 |
Why?
|
| Rumen | 2 | 2010 | 13 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 145 | 0.050 |
Why?
|
| Hindlimb | 3 | 2008 | 80 | 0.050 |
Why?
|
| Cerebellum | 2 | 2023 | 417 | 0.050 |
Why?
|
| Tyrosine | 3 | 2008 | 154 | 0.050 |
Why?
|
| Scintillation Counting | 1 | 2001 | 6 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 33 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 547 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2001 | 207 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2001 | 100 | 0.040 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2000 | 24 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 98 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 126 | 0.040 |
Why?
|
| Poly A | 1 | 2000 | 59 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2004 | 698 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2000 | 77 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2000 | 63 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 102 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 182 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2007 | 1007 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 411 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2001 | 201 | 0.040 |
Why?
|
| Ribosomes | 1 | 2000 | 137 | 0.040 |
Why?
|
| Basement Membrane | 1 | 2000 | 48 | 0.040 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1997 | 43 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2020 | 116 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 315 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2000 | 196 | 0.040 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2019 | 14 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2020 | 208 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2020 | 182 | 0.040 |
Why?
|
| Receptors, Somatomedin | 1 | 1999 | 25 | 0.040 |
Why?
|
| Sermorelin | 1 | 1998 | 2 | 0.040 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 1998 | 3 | 0.040 |
Why?
|
| Survival Rate | 1 | 2004 | 2062 | 0.040 |
Why?
|
| Receptors, Neuropeptide | 1 | 1998 | 9 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 676 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 2 | 2000 | 75 | 0.040 |
Why?
|
| Autoradiography | 1 | 1998 | 69 | 0.040 |
Why?
|
| Biological Transport | 1 | 2019 | 356 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 112 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 1756 | 0.040 |
Why?
|
| Diet, Protein-Restricted | 2 | 1997 | 81 | 0.040 |
Why?
|
| Retinol-Binding Proteins | 2 | 1996 | 21 | 0.040 |
Why?
|
| Prealbumin | 2 | 1996 | 26 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 191 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 230 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 584 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 175 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2002 | 941 | 0.040 |
Why?
|
| Shrews | 1 | 2017 | 5 | 0.040 |
Why?
|
| Birth Weight | 1 | 2019 | 345 | 0.040 |
Why?
|
| alpha-Tocopherol | 2 | 2008 | 38 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1998 | 194 | 0.040 |
Why?
|
| Serum Albumin | 4 | 2001 | 113 | 0.030 |
Why?
|
| Radioactive Tracers | 2 | 2012 | 21 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2021 | 14030 | 0.030 |
Why?
|
| Lactation | 1 | 1999 | 192 | 0.030 |
Why?
|
| Cell Movement | 1 | 2001 | 847 | 0.030 |
Why?
|
| Ligands | 1 | 1998 | 539 | 0.030 |
Why?
|
| Arteries | 2 | 1999 | 225 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 121 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 490 | 0.030 |
Why?
|
| Motor Activity | 1 | 2020 | 520 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 101 | 0.030 |
Why?
|
| Carbon | 1 | 1997 | 92 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 213 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 421 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2058 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 208 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 46 | 0.030 |
Why?
|
| Aminopeptidases | 2 | 2009 | 15 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 312 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 433 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 541 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 91 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1527 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 135 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 571 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 281 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2017 | 6168 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 762 | 0.030 |
Why?
|
| Cognition | 1 | 2020 | 728 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 810 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 128 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 686 | 0.030 |
Why?
|
| Ammonia | 1 | 1994 | 75 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 2 | 2004 | 144 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2001 | 1899 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 1994 | 403 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 19373 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1397 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 90 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 308 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 144 | 0.030 |
Why?
|
| Mucins | 1 | 2012 | 75 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1711 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2013 | 120 | 0.020 |
Why?
|
| Hepatic Veins | 1 | 2012 | 22 | 0.020 |
Why?
|
| Bifidobacterium | 1 | 2012 | 62 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2006 | 282 | 0.020 |
Why?
|
| Fibrinogen | 3 | 1998 | 156 | 0.020 |
Why?
|
| Litter Size | 1 | 1991 | 24 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 506 | 0.020 |
Why?
|
| Mesentery | 1 | 2011 | 27 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 352 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 354 | 0.020 |
Why?
|
| Stomach, Ruminant | 1 | 2010 | 1 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1990 | 61 | 0.020 |
Why?
|
| Glucose Clamp Technique | 2 | 2002 | 76 | 0.020 |
Why?
|
| Thyroxine | 1 | 1990 | 65 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2011 | 149 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 161 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2894 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2176 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 140 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 26990 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 363 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4824 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 29692 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3306 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 51 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2006 | 37 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 56 | 0.020 |
Why?
|
| fas Receptor | 1 | 2006 | 41 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 71 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 84 | 0.020 |
Why?
|
| Mannitol | 1 | 2006 | 48 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 162 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 89 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 159 | 0.020 |
Why?
|
| Causality | 1 | 2006 | 84 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1996 | 155 | 0.020 |
Why?
|
| Bilirubin | 1 | 2006 | 124 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 141 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Plasma | 2 | 1996 | 15 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2011 | 985 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 320 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 309 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 217 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2005 | 49 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 3746 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 479 | 0.010 |
Why?
|
| Consciousness | 1 | 2004 | 49 | 0.010 |
Why?
|
| Antioxidants | 1 | 2006 | 369 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2003 | 52 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9069 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 52 | 0.010 |
Why?
|
| Motilin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 381 | 0.010 |
Why?
|
| Manometry | 1 | 2002 | 57 | 0.010 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 153 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2001 | 48 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3103 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2001 | 8 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2001 | 7 | 0.010 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2001 | 18 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 257 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 2000 | 9 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2000 | 41 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 1186 | 0.010 |
Why?
|
| Lactates | 1 | 1999 | 94 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1998 | 71 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 163 | 0.010 |
Why?
|
| Mathematics | 1 | 1998 | 97 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 1998 | 67 | 0.010 |
Why?
|
| Albumins | 1 | 1998 | 93 | 0.010 |
Why?
|
| Body Fluid Compartments | 1 | 1998 | 19 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 1998 | 4 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1998 | 79 | 0.010 |
Why?
|
| Dimerization | 1 | 1998 | 144 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1997 | 40 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1997 | 47 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1997 | 53 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1996 | 19 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 261 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1996 | 17 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1996 | 54 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 106 | 0.010 |
Why?
|
| Haptoglobins | 1 | 1996 | 15 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 168 | 0.010 |
Why?
|
| Transferrin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 258 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1996 | 81 | 0.010 |
Why?
|
| Water | 1 | 1996 | 186 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1996 | 125 | 0.010 |
Why?
|
| Muscular Atrophy | 1 | 1996 | 75 | 0.010 |
Why?
|
| Edema | 1 | 1996 | 136 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1994 | 35 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1994 | 134 | 0.010 |
Why?
|
| Bone Density | 1 | 1996 | 319 | 0.010 |
Why?
|
| Skin | 1 | 1996 | 519 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1991 | 26 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1991 | 44 | 0.010 |
Why?
|
| United States | 1 | 2004 | 10936 | 0.000 |
Why?
|